SG3 Management’s Hologic HOLX Stock Holding History

SG3 Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40,000	Closed	-$2.67M	–	1097
2021 Q2	$2.67M	Buy	+40,000	New	+$2.67M	0.09%	243
2020 Q3	–	Sell	-7,700	Closed	-$439K	–	960
2020 Q2	$439K	Buy	+7,700	New	+$378K	0.03%	404

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

SG3 Management's HOLX Position: Q1 2022 in Review

SG3 Management sold out of Hologic (HOLX) in Q1 2022, closing a stake of 1,000 shares — an estimated $77K sold.

SG3 Management first reported a position in HOLX in Q2 2020 and held it in 3 quarters. The position peaked at $342K in Q2 2020. 700 funds tracked by Wall St. Rank hold HOLX as of Q1 2022.

SG3 Management reported no remaining Hologic position as of Q1 2022 after selling out during the quarter.
SG3 Management sold 1,000 Hologic shares in Q1 2022, an estimated $77K.
SG3 Management first reported a position in Hologic in Q2 2020 and held it in 3 quarters.
SG3 Management's Hologic position peaked at $342K in Q2 2020.
700 funds tracked by Wall St. Rank held Hologic as of Q1 2022.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.